Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2009
08/04/2009US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome
08/04/2009US7569516 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives
08/04/2009CA2425984C 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their preparation processes and uses
07/2009
07/30/2009WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides
07/30/2009WO2009094224A1 Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
07/30/2009WO2009092432A1 Beta-amino acid derivatives for treatment of diabetes
07/30/2009WO2009021126A8 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group
07/30/2009WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof
07/30/2009WO2008103613A3 Hydroxylamine compounds and methods of their use
07/30/2009US20090192307 antiinflammatory agents; 1-[5-tert-butyl-3-(1,1-dioxo-1 lambda 6-[1,2,5]thiadiazepane-5-carbonyl)thiophen-2-yl]-3-[4-(pyridin-4-yloxy)phenyl]urea; enzyme inhibitors
07/30/2009US20090192206 Mercaptoimidazoles as ccr2 receptor antagonists
07/30/2009US20090192191 Substituted hydroxamic acid derivatives as tnf inhibitors
07/30/2009US20090192179 Chroman derivatives
07/30/2009US20090192175 Insecticidal compounds
07/30/2009US20090192159 Substituted gamma lactams as therapeutic agents
07/30/2009US20090192157 Indole compounds and methods for treating visceral pain
07/30/2009US20090189120 Compound, liquid crystal composition, and anisotropic material
07/30/2009CA2712998A1 Beta-amino acid derivatives for treatment of diabetes
07/30/2009CA2712777A1 5-fluoro pyrimidine derivatives as fungicides
07/29/2009EP2083014A2 Inhibitors of interleukin-1ß converting enzyme
07/29/2009EP2081923A1 Certain substituted amides, method of making, and method of use thereof
07/29/2009EP2081910A1 Novel compounds
07/29/2009EP2081903A2 2-aminocarbonyl-pyridine derivatives
07/29/2009EP2081894A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
07/29/2009EP2081892A1 Compounds and methods for treating protein folding disorders
07/29/2009EP2081572A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
07/29/2009EP1989200B1 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
07/29/2009EP1926712B1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
07/29/2009EP1807407B1 Aromatic amides as inhibitors of c-fms kinase
07/29/2009EP1748982B1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
07/29/2009EP1660450A4 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbazoles
07/29/2009CN101495474A Thiophene-carboxamides useful as inhibitors of protein kinases
07/29/2009CN101492416A Compounds effecting glucokinase
07/29/2009CN100519557C Dithiophene ethene functional material, and its preparing method and use
07/29/2009CN100519554C CCR5 antagonists for treating aids
07/29/2009CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3
07/29/2009CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds
07/29/2009CN100519528C Compounds with analgesic effect
07/29/2009CN100519527C Inhibitors of histone deacetylase
07/29/2009CN100518736C Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
07/28/2009US7566791 Substituted 3-carbonyl-1h-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
07/28/2009US7566789 2-[2-(5-chlorothiophen-2-yl)-1H-benzimidazol-5-yl]-N-[4-(3-oxomorpholin-4-yl)phenyl]acetamide; anticoagulants of blood factor Xa; treating thromboembolic diseases, thrombosis; antitumor agent for treating of tumours
07/28/2009US7566786 enzyme inhibitor 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; antiinflammatory agents for treatment, prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis
07/28/2009US7566734 Imidazolyl derivatives
07/28/2009US7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
07/28/2009US7566718 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
07/28/2009US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
07/28/2009US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics
07/28/2009CA2370147C Piperidine-indole compounds having 5-ht6 affinity
07/23/2009WO2009091898A2 6-and 7-amino isoquinoline compounds and methods for making and using the same
07/23/2009WO2009091764A2 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss
07/23/2009WO2009090548A2 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
07/23/2009WO2009023664A3 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
07/23/2009WO2008103351A3 Heterocyclic aspartyl protease inhibitors
07/23/2009WO2008061796A3 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
07/23/2009US20090186921 Azacyclic compounds
07/23/2009US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
07/23/2009US20090186875 Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer
07/23/2009US20090186871 Tyrosine kinase inhibitors
07/23/2009CA2712443A1 6- and 7-amino isoquinoline compounds and methods for making and using the same
07/23/2009CA2712264A1 Therapeutic beta-lactams
07/22/2009EP2079733A2 5- and 6-substituted benzimidazole thiophene compounds
07/22/2009EP2079731A1 Novel substituted piperidyl-propane-thiols
07/22/2009EP2079729A1 Compounds and compositions as protein kinase inhibitors
07/22/2009EP2079728A1 N-aryl pyrazole compounds for use against diabetes
07/22/2009EP2079703A1 Indazole derivatives useful as l-cpt1 inhibitors
07/22/2009EP2079701A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2009EP2079693A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors
07/22/2009EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives
07/22/2009EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
07/22/2009EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof
07/22/2009EP1503988B1 Fredericamycin derivatives
07/22/2009EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
07/22/2009EP1391456B1 2-iminoimidazole derivatives
07/22/2009CN101490045A Process for preparing 7- (acryl0yl) -ind0les
07/22/2009CN101490044A 1,4-bis(2-thienylvinyl)benzol derivatives and their use
07/22/2009CN101486679A 5HT2c receptor modulators
07/22/2009CN101486678A 5HT2C receptor modulators
07/22/2009CN101486677A 5HT2c receptor modulators
07/22/2009CN101486675A 2- and 2,5-substituted phenylketoenols
07/22/2009CN101485664A 5HT2c receptor modulators
07/22/2009CN100515419C Substituted benzazoles and its application as inhibitors of Raf kinase
07/21/2009US7563911 Process for the preparation of amorphous atorvastin calcium salt (2:1)
07/21/2009US7563905 Triazole derivatives and method of using the same to treat HIV infections
07/21/2009US7563813 Iminothiazolidinone derivatives as SFRP-1 antagonists
07/21/2009US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
07/21/2009US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation
07/16/2009WO2009089462A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
07/16/2009WO2009089235A1 Preparation of sulfamide derivatives
07/16/2009WO2009088070A1 (heterocyclic methyl)azolylmethylcyclopentanol derivative and intermediate thereof, process for production of the derivative, and agricultural or horticultural preparation and protective agent for industrial material each comprising the derivative
07/16/2009WO2009087564A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain
07/16/2009WO2009087212A2 Pyridine derivatives
07/16/2009US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/16/2009US20090182140 Alicyclic Heterocyclic Compound
07/16/2009US20090182033 Cyclic Amine Derivatives and Their Uses
07/16/2009US20090182013 Derivatives of 5-Thioxylopyranose and Use of Same for Treatment
07/16/2009US20090182011 Chimeric Nitrate Esters and Use of the Same in a Treatment for Depression
07/16/2009US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/16/2009US20090181979 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
07/16/2009US20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides